do glp 1 meds cause blindness Does GLP-1 Eye Problems? Retinopathy Risks Explained GLP 1 Blindness Risk |

Description

The results of a phase 2 trial of the triple agonist LY3437943 (Retatrutide) showed 24.2% weight loss at the highest dose (12 mg) in 48 weeks (83)

But the needs of GLP-1 users could evolve significantly as new drugs come onto the market

Lily, who asked to be identified by only her first name because she is not out to her family as transgender, has tried other medications since then, and previously tried lifestyle programs to control her weight

Researchers are conducting a systematic review on dual agonists

Red flag symptoms requiring urgent medical attention include: Severe, persistent abdominal pain, especially if radiating to the back and accompanied by vomiting (possible pancreatitis) Pain in the upper right abdomen, fever, or yellowing of the skin/eyes (possible gallbladder disease) Blood in vomit or stools Signs of severe dehydration (dark urine, dizziness, confusion) High fever (above 38C) accompanying digestive symptoms Unexplained weight loss beyond expected treatment effects Severe, persistent diarrhoea lasting more than 48 hours If you experience these red flag symptoms, call NHS 111 for advice or 999 in an emergency